Neurogene pockets $115m Series B
Neurogene Inc, a gene therapy company, has secured $115 million in Series B financing.
Neurogene Inc, a gene therapy company, has secured $115 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination